Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.

about

Cholinesterases and the fine line between poison and remedy.Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study.

P2860

Q50152965-1C8A26CC-43B9-4EC8-8DCF-53686FF7537E Q55093805-19CBF5CC-89F1-49F8-920C-65DFC66D4B20

P2860

Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.

Item

http://www.wikidata.org/entity/Q39415447

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.

@en

Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.

@nl

type

Item

label

Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.

@en

Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.

@nl

prefLabel

Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.

@en

Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.

@nl

P1476

Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.

@en

P2093

Dana Mohammad

http://www.w3.org/2001/XMLSchema#string

Janelle Bradley

http://www.w3.org/2001/XMLSchema#string

Nathan Herrmann

http://www.w3.org/2001/XMLSchema#string

Parco Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Cholinesterase inhibitors for Alzheimer's disease

Donepezil for dementia due to Alzheimer's disease

Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada

Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study.

Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.

Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials.

Cardiovascular effects of drugs used to treat Alzheimer's disease.

The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.

Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence.

Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.

P304

1009-1019

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14740338.2017.1351540

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Krista L Lanctôt

P577

2017-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28678552

http://www.w3.org/2001/XMLSchema#string

Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.

about

P2860

P2860

Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698